Dukes' disease
Dukes' disease, also known as fourth disease, is a condition that was historically classified as one of the common childhood exanthems. It was once considered a distinct disease, but its existence as a separate entity has been questioned and is now largely considered obsolete.

History[edit]
Dukes' disease was first described in the early 20th century by the English physician Clement Dukes. It was initially thought to be a separate exanthematic disease, similar to measles, scarlet fever, and rubella. However, subsequent research has suggested that cases attributed to Dukes' disease were likely misdiagnosed instances of other conditions, such as roseola or mild forms of scarlet fever.
Clinical Presentation[edit]
The clinical presentation of Dukes' disease was described as a mild rash, often accompanied by fever and other systemic symptoms. The rash was typically erythematous and maculopapular, resembling that of other childhood exanthems.
Etiology[edit]
The exact cause of Dukes' disease was never definitively established. It was hypothesized to be caused by a bacterial or viral agent, but no specific pathogen was identified. Some researchers speculated that it might be related to Staphylococcus aureus infections, although this was never confirmed.
Current Understanding[edit]
Today, Dukes' disease is not recognized as a distinct medical condition. The symptoms once attributed to it are now understood to be manifestations of other well-defined diseases. The term "fourth disease" is rarely used in modern medical practice.
Related Pages[edit]
| Childhood Diseases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This childhood diseases related article is a stub.
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian